Cargando…
Tocilizumab and PMX-DHP have efficacy for severe COVID-19 pneumonia
In coronavirus disease 2019 pneumonia, a cytokine storm resulting from an excessive inflammatory response to the viral infection is thought to play a role in the exacerbation of the pneumonia and its prognosis. Favipiravir and ciclesonide are not effective in the inhibition of the cytokine storm. In...
Autores principales: | Shinomiya, Shohei, Nakase, Keisuke, Fujii, Ai, Takahara, Yutaka, Adachi, Hiroki, Okuro, Masashi, Iinuma, Yoshitsugu, Yokoyama, Hitoshi, Ito, Toru, Mizuno, Shiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970680/ https://www.ncbi.nlm.nih.gov/pubmed/33796310 http://dx.doi.org/10.1177/2050313X21991063 |
Ejemplares similares
-
Is it true that PMX-DHP can improve lung oxygenation?
por: Ikeda, T, et al.
Publicado: (2003) -
Effect of PMX-DHP according to differences in infection site
por: Ikeda, T, et al.
Publicado: (2001) -
Observational study for direct hemoperfusion therapy with polymyxin-B immobilized fibers (PMX-DHP) in patients with septic shock in Japan: PMX-DHP study group
por: Kase, Y, et al.
Publicado: (2009) -
A retrospective investigation of the pmx-dhp's efficacy in 88 severe sepsis cases
por: Tanaka, M, et al.
Publicado: (2015) -
The role of plasminogen activator inhibitor 1 measurement with endotoxin adsorption therapy (PMX-DHP) for postoperative septic shock patients
por: Ikeda, T, et al.
Publicado: (2007)